HSIC News

Pearl Joins Henry Schein One API Exchange as an Authorized Integration Vendor

HSIC

(NASDAQ:HSIC) LOS ANGELES--(BUSINESS WIRE)-- #ArtificialIntelligence--Pearl joins Henry Schein One API Exchange, integrating with Dentrix and Dentrix Ascend to deliver secure AI tools that boost efficiency and care.

September 16, 2025Partnerships
Read more →

Henry Schein Announces $750 Million Share Repurchase Plan

HSIC

(NASDAQ:HSIC) MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein, Inc. (Nasdaq: HSIC), the world's largest provider of health care products and services to office-based dental and medical practitioners, announced today that its Board of Directors has authorized the repurchase of up to $750 million of shares of the Company's common stock. This program is in addition to the $500 million repurchase program announced in January 2025, which is anticipated to be fully executed by the end of the first quarter of 2026. T

September 9, 2025Buybacks
Read more →

Worldpay & Henry Schein One: Exclusive Partnership Powers Dental Practices

HSIC

CINCINNATI--(BUSINESS WIRE)--Today, Worldpay® announced it will continue as the exclusive provider of embedded payments for Henry Schein One in a long-term agreement. Since 2004, Worldpay has been the trusted payments partner to Henry Schein One, North America’s leading dental software provider serving more than 75,000 practices. This partnership has elevated Henry Schein One’s payments business into a powerful driver of revenue and growth while enhancing the experience for its clients and thei

Henry Schein to Participate in Upcoming Investor Conferences in September

HSIC

MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein, Inc., the world’s largest provider of health care solutions to office-based dental and medical practitioners, announced today that the Company will present at the following investor conferences in September: Wells Fargo Healthcare Conference at the Encore Boston hotel, Boston, MA, on September 4, 2025, at 11:00 a.m. EST. Baird Global Healthcare Conference at the InterContinental hotel, New York City, on September 10, 2025, at 10:50 a.m. EST. Bank o

Henry Schein’s 28th Annual ‘Back to School’ Program Supports Students Worldwide

HSIC

MELVILLE, N.Y.--(BUSINESS WIRE)--For the 28th consecutive year, Henry Schein, Inc. (Nasdaq: HSIC) is helping students worldwide start the academic year off right through its “Back to School” program, a flagship initiative of Henry Schein Cares, the Company’s global corporate citizenship program. Team Schein Members (TSMs) at 45 locations in the U.S., Canada, Italy, Spain, the U.K., and Ireland are helping more than 5,200 students gain confidence and excitement for the school year. Since 1998, H

August 19, 2025CSR
Read more →

Henry Schein Reports Second Quarter 2025 Financial Results

HSIC

MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein, Inc. (Nasdaq: HSIC), the world’s largest provider of health care solutions to office-based dental and medical practitioners, today reported financial results for the second quarter ended June 28, 2025. “We had good sales growth in our Global Distribution Group this quarter while experiencing lower margins in the U.S. versus the prior year primarily resulting from lower glove pricing as well as time-limited targeted sales initiatives. We are pleased

August 5, 2025Earnings
Read more →

Henry Schein One Unveils 2025 Catalyst Index Revealing Key Strategies Driving Top 10% Of Dental Practices And DSOs

HSIC

May 20, 2025
Read more →

Henry Schein Completes $250M Of Strategic Investment By Funds Affiliated With KKR

HSIC

May 16, 2025
Read more →

These Analysts Lower Their Forecasts On Henry Schein Following Q1 Results

HSIC

May 6, 2025
Read more →

Wells Fargo Maintains Equal-Weight on Henry Schein, Lowers Price Target to $75

HSIC

May 6, 2025
Read more →

Barrington Research Maintains Outperform on Henry Schein, Lowers Price Target to $86

HSIC

May 6, 2025
Read more →

Henry Schein's Reports Mixed Bag Q1 Earnings, CEO Confident In Business Fundamentals

HSIC

Henry Schein affirms 2025 EPS outlook and projects 2%–4% sales growth, recording $25 million in restructuring costs in Q1 2025.

May 5, 2025
Read more →

Henry Schein Affirms FY2025 Adj EPS Guidance of $4.80-$4.94 vs $4.86 Est; Affirms FY2025 Sales Guidance of $12.43B-$13.18B vs $13.00B Est

HSIC

May 5, 2025
Read more →

Henry Schein Q1 Adj. EPS $1.15 Beats $1.11 Estimate, Sales $3.17B Miss $3.23B Estimate

HSIC

May 5, 2025
Read more →

Piper Sandler Maintains Overweight on Henry Schein, Lowers Price Target to $77

HSIC

April 30, 2025
Read more →

James P. Breslawski To Step Down As President Of Henry Schein

HSIC

March 14, 2025
Read more →

Breaking Down Henry Schein: 7 Analysts Share Their Views

HSIC

February 26, 2025
Read more →

UBS Maintains Neutral on Henry Schein, Lowers Price Target to $80

HSIC

February 26, 2025
Read more →

Barrington Research Maintains Outperform on Henry Schein, Maintains $90 Price Target

HSIC

February 26, 2025
Read more →

Henry Schein Q4 Earnings And Outlook Miss Expectations, Restructures For Growth

HSIC

Henry Schein Q4 sales grew 5.8% to $3.19 billion, missing estimates. The company was restructured into three segments.

February 25, 2025
Read more →

Henry Schein Forecasts 2025 Adjusted EPS Of $4.80-$4.94 Versus Consensus Of $5.01, With Sales Growth Of Approximately 2%-4% Over 2024

HSIC

February 25, 2025
Read more →

Henry Schein Q4 2024 Adj EPS $1.19 Misses $1.21 Estimate, Sales $3.18B Miss $3.30B Estimate

HSIC

February 25, 2025
Read more →

Wells Fargo Initiates Coverage On Henry Schein with Equal-Weight Rating, Announces Price Target of $80

HSIC

February 14, 2025
Read more →

Henry Schein Signed An Agreement To Acquire Acentus, A National Medical Supplier Specializing In The Delivery Of Continuous Glucose Monitors (cgms), For An Undisclosed Amount

HSIC

November 20, 2024
Read more →

Activist Investor Ananym Capital Pushes For Changes At Henry Schein; Ananym Wants Refreshed Board, CEO Succession Plan, Review Of Alternatives For Medical Distribution Business; Ananym Argues Changes Could Push Up Share Price, Earnings

HSIC

November 18, 2024
Read more →

Barrington Research Maintains Outperform on Henry Schein, Maintains $82 Price Target

HSIC

November 6, 2024
Read more →

Henry Schein Q3 Earnings: Sees Recovery From Cyber Incident, Says Dental Equipment Business Shows Stability In North America

HSIC

Henry Schein posts Q3 adjusted EPS of $1.23, topping forecasts, while sales of $3.17 billion fall short. The company revises full-year EPS guidance upwards.

November 5, 2024
Read more →

Henry Schein Expects 2024 Adjusted EPS Of $4.74 To $4.82 Compared With Prior Guidance Of $4.70-$4.82 And Consensus Of $4.75

HSIC

November 5, 2024
Read more →

Henry Schein Q3 2024 Adj EPS $1.22 Beats $1.17 Estimate, Sales $3.17B Miss $3.24B Estimate

HSIC

November 5, 2024
Read more →

Henry Schein Q1 Earnings Beat Street View, Sticks To FY22 Guidance

HSIC

May 3, 2022
Read more →

Recap: Henry Schein Q1 Earnings

HSIC

Henry Schein (NASDAQ:HSIC) reported its Q1 earnings results on Tuesday, May 3, 2022 at 06:30 AM. Here's what investors need to know about the announcement.

May 3, 2022
Read more →

Henry Schein Q1 EPS $1.30 Beats $1.19 Estimate, Sales $3.20B Beat $3.13B Estimate

HSIC

May 3, 2022
Read more →